These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of in vitro assays in selection of compatible platelet donors. Tosato G; Appelbaum FR; Trapani RJ; Dowling R; Deisseroth AB Transfusion; 1980; 20(1):47-54. PubMed ID: 7355471 [TBL] [Abstract][Full Text] [Related]
7. The relationship between donor-recipient lymphocytotoxicity and the transfusion response using HLA-matched platelet concentrates. Herzig RH; Terasaki PI; Trapani RJ; Herzig GP; Graw RG Transfusion; 1977; 17(6):657-61. PubMed ID: 595123 [TBL] [Abstract][Full Text] [Related]
8. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates. O'Connell BA; Lee EJ; Rothko K; Hussein MA; Schiffer CA Blood; 1992 Jan; 79(2):527-31. PubMed ID: 1730095 [TBL] [Abstract][Full Text] [Related]
9. Platelet crossmatching with lymphocytotoxicity test: an effective method in alloimmunized Chinese patients. Chow MP; Yung CH; Hu HY; Tzeng JL; Lin WM; Lin CK Transfusion; 1991 Sep; 31(7):595-9. PubMed ID: 1891789 [TBL] [Abstract][Full Text] [Related]
11. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Heal JM; Blumberg N; Masel D Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041 [TBL] [Abstract][Full Text] [Related]
12. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection. Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of four methods for platelet compatibility testing. McFarland JG; Aster RH Blood; 1987 May; 69(5):1425-30. PubMed ID: 3552075 [TBL] [Abstract][Full Text] [Related]
14. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets]. Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437 [TBL] [Abstract][Full Text] [Related]
15. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience. Karlström C; Linjama T; Edgren G; Lauronen J; Wikman A; Höglund P Transfusion; 2019 Mar; 59(3):945-952. PubMed ID: 30575964 [TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients. Freedman J; Gafni A; Garvey MB; Blanchette V Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693 [TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients. Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762 [TBL] [Abstract][Full Text] [Related]
18. Random donor platelet crossmatching: comparison of four platelet antibody detection methods. Freedman J; Garvey MB; Salomon de Friedberg Z; Hornstein A; Blanchette V Am J Hematol; 1988 May; 28(1):1-7. PubMed ID: 3285667 [TBL] [Abstract][Full Text] [Related]
19. Solid phase platelet crossmatching versus complement dependent lymphocytotoxicity--clinical utility. Lane D; Shivji S; Turner AR Prog Clin Biol Res; 1990; 337():59-62. PubMed ID: 2353019 [No Abstract] [Full Text] [Related]
20. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets. Levy L; Woodfield DG N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]